21/7'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
L77'CL, ANTI-HUMAN CD4
A17'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
RF-ET11'CL, RHEUMATOID FACTOR
1B5'CL, ANTI-FECAL BACTERIA
Clone F'CL, RHEUMATOID FACTOR WHICH BOUND SPECIFICALLY TO MRL IGG2A ALLOTYPE (IGH-1J) BUT NOT B6 IGG2A ALLOTYPE (IGH-1B)
6-4'CL, ANTI-IGG2A
1-5F6'CL, ANTI-SM HYBRIDOMA
25G07, ANTI-LYSOZYME HYBRIDOMA
GER, MONOCLONAL CRYOIMMUNOGLOBULIN
bkv7'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
SA-4A'CL, ANTI-TITIN AUTOANTIBODY
126TP6H'CL, ANTI-THYROID PEROXIDASE (TPO)
1E8'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
Ab1 GA733'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
B/SB5-72'CL, ANTI-H4
305'CL, ANTI-INSULIN
34-3C'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
Vl FUR2'CL, ANTI-LAMIN B AUTOANTIBODY
Hb-3, ANTI-FOETAL HAEMOGLOBIN (HBF)
2F6F2'CL, ANTI-TG
VH FUR2'CL, ANTI-LAMIN B AUTOANTIBODY
RF-ET9'CL, RHEUMATOID FACTOR
D15'CL, ANTI-RH(D)
TB-1-P7'CL, RHEUMATOID FACTOR
1-18'CL, ANTI-SM HYBRIDOMA
RF4-3FK'CL, ANTI-IGG1
3B12-3'CL, ANTI-88 KDA SPLICING FACTOR 53/4
BrM4'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
G10-1'CL, ANTI-HUMAN CD8
3G2'CL, ANTI-SM HYBRIDOMA
A12'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
2INL2'CL, ANTI-HUMAN INSULIN
7F'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
RF-TMC'CL, MONOREACTIVE RHEUMATOID FACTOR
D83, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
43F10'CL, ANTI-RH(D)
4D11F4'CL, ANTI-TG
AHT107'CL, ANTI-HUMAN P55 IL-2 RECEPTOR
bkv33'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
CEA4-8A'CL, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
2INL7'CL, ANTI-HUMAN INSULIN
72-2'CL, ANTI-PERIPHERIN AUTOANTIBODY
RF-4 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
3-7'CL, ANTI-SM, ANTI-SSDNA
TEL13'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
B5G10H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
Z122VH5'CL, CD20
HA-3'CL, ANTI-ERYTHROCYTE
1-2'CL, ANTI-IGG2A
RF-IP9'CL, RHEUMATOID FACTOR
E11, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
Ab2 A'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
EL-25'CL, ANTI-FACTOR VIII
D10'CL, ANTI-RH(D)
LAY, ANTI-HUMAN GAMMA G1 AND G3 GLOBULINS; PO IDIOTYPE
126TP7H'CL, ANTI-THYROID PEROXIDASE (TPO)
II-481'CL, ANTI-GE, THE HERPES SIMPLEX VIRUS-1 FCG-BINDING PROTEIN
15E8'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
LES-A'CL, RHEUMATOID FACTOR
N19-8 scFv'CL, ANTI-HUMAN COMPLEMENT C5 CONVERTASE
Jac-10'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
T10-421'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
SER'CL, AUTOANTIBODY
1G2'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
CBLC235.7'CL, ANTI-BACTERIAL LEVAN
C05'CL, ANTI-RH(D)
C1'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
414.2'CL, ANTI-B1335 DEX
AC38 251.5, ANTIBODY AC38-POSITIVE HYBRIDOMA
6H-3C4'CL, HUMAN SPERM-IMMOBILIZING ANTIBODY
D7'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
LC4'CL, ANTI-CD19
2INL10'CL, ANTI-HUMAN INSULIN
3B8G9'CL, ANTI-TG
4C8'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
A1'CL, ANTI-GLYCOPHORIN A
B43'CL, ANTI-CD19
JV2'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
ALN/16/53'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
CBLC270.1'CL, ANTI-BACTERIAL LEVAN
ALN/9/94'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
10/8'CL, ANTI-PROGESTERONE HYBRIDOMA
CG-6'CL, ANTI-ERYTHROCYTE
VL A30, ANTI-CD34
Z18VH4'CL, CD20
Z112VH3'CL, CD20
10.2.3'CL, ANTI-GROUP A STREPTOCOCCAL M PROTEIN, SKELETAL MYOSIN, CARDIAC MYOSIN, LIGHT MEROMYOSIN
A09, ANTI-LYSOZYME HYBRIDOMA
39-A11, CATALYTIC ANTIBODY WHICH CATALYSES A DIELS-ALDER REACTION
PE23'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
J02'CL, ANTI-RH(D)
126TP8H'CL, ANTI-THYROID PEROXIDASE (TPO)
6A7.E5'CL, ANTI-RAT 62 CYTOCHROME C
68.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
HSCFV198, ANTI-ACHR
417.F32.36'CL, MONOREACTIVE
VL A47, ANTI-CD34
5G5'CL, ANTI-HUMAN PROCOLLAGENASE
18G9'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
133'CL, ANTI-KEY HOLE LIMPET HEMOCYANIN-COUPLED ANGIOTENSIN II
GN901v1.1, ANTI-CD56
SIE, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
C1'CL, ANTI-GLYCOPHORIN A
3F9L'CL, ANTI-MURINE SERUM ALBUMIN
126TO1H'CL, ANTI-THYROID PEROXIDASE (TPO)
hsiggll295'CL, ANTI-RABBIT IGG
N901L, ANTI-CD56
WG2'CL, ANTI-PROTEINASE 3
WRD2'CL, RHEUMATOID FACTOR
cDNA3-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
PR-SJ1'CL, POLYREACTIVE RHEUMATOID FACTOR
mAb67'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
7C5'CL, ANTI-SM
F1_1354'CL, ANTI-FRACTION 1
CDP571, ANTI-RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR-ALPHA
MRA1H'CL, ANTI-HISTONE
ARMVH'CL, ANTI-MYELIN ASSOCIATED PROTEIN
8'CL, ANTI-INSULIN
2.64'CL, ANTI-PNEUMOCOCCAL
10F10'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
E3'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
TR1.32'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
AF52, ANTI-ANTI-IDIOTYPIC, I.E. ANTI-E5.2 (AN ANTI-D1.3 WHICH IS ANTI-HEN EGG LYSOZYME), WITH KA (FAB E5.2) = 2.4 X 10EXP7 M AND KA (HEN EGG LYSOZYME) = 3.8 X 10EXP6 M
LOC'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
D115, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
F6-3'CL, ANTI-TEPC15 IDIOTYPE ANTIBODY HYBRIDOMA
88.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
N10'CL, ANTI-STAPHYLOCOCCAL NUCLEASE
SCFV198, ANTI-ACHR
B003=46/2D7'CL, ANTI-BLOOD GROUP B SUBSTANCE HYBRIDOMA
12-3-4'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
CLL'CL, ANTI-IGG (RHEUMATOID FACTOR)
VS3'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
scF11, ANTI-HUMAN FERRITIN
5E9''CL, ANTI-SM HYBRIDOMA
POM, ANTI-HUMAN GAMMA G1 GLOBULIN; PO IDIOTYPE
C219'CL, ANTI-P-GLYCOPROTEIN
126JH'CL, ANTI-THYROID PEROXIDASE (TPO)
BrM1'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
C09, ANTI-LYSOZYME HYBRIDOMA
DS1F8'CL, NATURAL AUTO-ANTIBODY REACTIVE WITH OLIGODENDROCYTE
MUSE11'CL, ANTI-TANDEM REPEAT DOMAIN OF MUCIN CORE PROTEIN MUC1
M25-9'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
126TP9H'CL, ANTI-THYROID PEROXIDASE (TPO)
HN.14'CL, ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN HYBRIDOMA
slkv11'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
AF5'CL, ANTI-HUMAN ALPHA-FETOPROTEIN
LS5'CL, ANTI-PR2 RBC AUTOANTIBODY
82B6a'CL, AUTOANTIBODY TO THYROGLOBULIN
126TO2H'CL, ANTI-THYROID PEROXIDASE (TPO)
56R-9'CL, ANTI-3M-1/ANTI-TUBULAR BASEMENT MEMBRANE
1H12'CL, ANTI-LAMININ RECEPTOR OF STAPHYLOCOCCUS AUREUS
S10P19'CL, RHEUMATOID FACTOR
PE17'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
PR-SJ2'CL, POLYREACTIVE RHEUMATOID FACTOR
L2 8C'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
9-12'CL, ANTI-IGG2A
HP12'CL, ANTI-PRIVATE IDIOTYPE HYBRIDOMA OF THE GAT SYSTEM
MRA3K'CL, ANTI-HISTONE
L93'CL, ANTI-HUMAN CD4
LOI, ANTI-COMPLEMENT FACTOR H (LIGHT CHAIN DIMER)
L24'CL, AUTOANTIBODY
MIMA-8'CL, ANTI-JS(B+)
IN-1'CL, ANTI-MYELIN-ASSOCIATED INHIBITORS OF NEURITE GROWTH
Mc3'CL, ANTI-BA46 (A 46-KDA GLYCOPROTEIN OF THE HUMAN MILK FAT GLOBULE MEMBRANE EXPRESSED IN BREAST CARCINOMA CELLS)
9F9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
M2 87'CL, ANTI-MOUSE TYPE II COLLAGEN
anti-Leu3a'CL, ANTI-HUMAN CD4
cAbAM07, ANTI-ALPHA-AMYLASE
ESC'CL, AUTOANTIBODY
ASWA3'CL, ANTI-NUCLEOLAR PARTICLES U3, U8 AND FIBRILLARIN
53R-4'CL, ANTI-3M-1
22.94.4'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
717'CL, ANTI-P601E
C7'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
2INL12'CL, ANTI-HUMAN INSULIN
BMA 031 VH'CL, ANTI-HUMAN TCR-ALPHA/BETA
D31'CL, ANTI-RH(D)
TR1.6'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
10C9'CL, REACTS WITH HUMAN IGG.
PD1'CL, ANTI-CHROMATIN
C04, ANTI-LYSOZYME HYBRIDOMA
scFv03, POLYSPECIFIC
4F5'CL, ANTI-HUMAN PROCOLLAGENASE
N901L/KV4B, ANTI-CD56
FOG1-G8'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
RF-ET10'CL, RHEUMATOID FACTOR
F9A7'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
HA3D1'CL, RHEUMATOID FACTOR
105-2H'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
163.9, ANTI-P53
HD37'CL, ANTI-CD19
82H'CL, ANTI-R585, A RABBIT ANTI-TAXOL ANTIBODY 
E7'CL, POLYREACTIVE AUTOANTIBODY HYBRIDOMA
Fog-B'CL, ANTI-D ANTIGEN OF THE RH-BLOOD-GROUP SYSTEM
N02'CL, ANTI-RH(D)
HP29'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
57R-1'CL, ANTI-3M-1/ANTI-TUBULAR BASEMENT MEMBRANE
L2 11C'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
RF-FO2'CL, RHEUMATOID FACTOR
b'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
B7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
AD3/15'CL, ANTI-ERYTHROCYTE RH(D) 
B5G10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
GG3'CL, RHEUMATOID FACTOR
3C10'CL, ANTI-FECAL BACTERIA
slkv12'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
RF-KES1'CL, RHEUMATOID FACTOR AUTOANTIBODY
12IIB6'CL, AUTOANTIBODY TO THYROGLOBULIN
DM1'CL, KIM11.4
417.F14'CL, MONOREACTIVE TO BETA-GALACTOSIDASE
126TO3H'CL, ANTI-THYROID PEROXIDASE (TPO)
2E7'CL, ANTI-PLATELET INTEGRIN GPIIB-IIIA IIB HEAVY CHAIN (RES. 231-238)
L37'CL, AUTOANTIBODY
mAb A41 kappa-1'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
M74 (VH3-JH4)'CL, RHEUMATOID FACTOR
2INL13'CL, ANTI-HUMAN INSULIN
PE2'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR
CB 268'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
Ab3 CE5'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
B12'CL, ANTI-TG
4B4'CL, ANTI-HUMAN PROCOLLAGENASE
mAb 124'CL, ANTI-INSULIN
417.32.E4.8.5'CL, MONOREACTIVE
CLONE 1D8'CL, ANTI-HUMAN RED BLOOD CELL
LAR'CL, RHEUMATOID FACTOR
SCH94.03'CL, ANTI-SPECTRIN AUTOANTIBODY
MabA34'CL, ANTI-HUMAN PLASMA APOLIPOPROTEIN A-1
AC38 15.3, ANTIBODY AC38-POSITIVE HYBRIDOMA
RF2-4'CL, ANTI-IGG2A
I05'CL, ANTI-RH(D)
BBLC1.1'CL, ANTI-BACTERIAL LEVAN
PAC1'CL, ANTI-PLATELET FIBRINOGEN RECEPTOR.
MBr1'CL, ANTI-HUMAN MAMMARY CARCINOMA LINE MCF-7 HYBRIDOMA
163.20, ANTI-P53
Ab1 CO17-1A'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
RF4-3FA'CL, ANTI-IGG1
slkv13'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
VH FUR1'CL, ANTI-LAMIN B AUTOANTIBODY
hsighvl295'CL, ANTI-RABBIT IGG
THY-23'CL, ANTI-HUMAN THYROGLOBULIN
RF-TS7'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
hu2.0, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
RF-FO3'CL, RHEUMATOID FACTOR
d'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
RF5-7'CL, ANTI-IGG2A
PE20'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
OVB3'CL, ANTI-OVARIAN CANCER CELLS
WIL'CL, RHEUMATOID FACTOR
MH6'CL, ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY
m33N/D, ANTI-IDIOTYPIC
S/SB5-37'CL, ANTI-H4
1F12'CL, ANTI-HUMAN PROCOLLAGENASE
B11'CL, ANTI-IDIOTYPE OF THE MURINE MAB RSV19
PAY, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
RF-IP20'CL, RHEUMATOID FACTOR
MAL'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
B'20 (VH3-JH4)'CL, RHEUMATOID FACTOR
FS-6'CL, COLD AGGLUTININ
3A3.C2'CL, ANTI-HORSE 60 CYTOCHROME C
10G9'CL, ANTI-IDIOTYPIC ANTIBODY TO THE MONOCLONAL ANTI-HALOPERIDOL ANTIBODY WITH SPECIFIC BINDING AFFINITY TO SIGMA RECEPTOR
2B12 (Dp2A)'CL, ANTI-DER P 2 (HOUSE DUST MITE ALLERGEN)
PY102''CL, ANTI-HEMAGGLUTININ OF PR8 (H1N1) VIRUS
723569, ANTI-TYPE VIII PNEUMOCOCCAL POLYSACCHARIDE
HA-VG'CL, ANTI-ERYTHROCYTE
RF2-9'CL, ANTI-IGG2A
2INL14'CL, ANTI-HUMAN INSULIN
heavy2'CL, ANTI-HUMAN THYROGLOBULIN
89'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
2G5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
D08'CL, ANTI-RH(D)
Meso 3, ANTI-RECOMBINANT MESOTHELIN, MESOTHELIN-POSITIVE CELLS
HB125'CL, ANTI-INSULIN
417.7.3.1'CL, POLYREACTIVE
3C3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
K-25, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
126TO10H'CL, ANTI-THYROID PEROXIDASE (TPO)
PE14'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
D03'CL, ANTI-RH(D)
Ab18'CL, POLYREACTIVE AUTOANTIBODY
SS, ANTI-RECOMBINANT MESOTHELIN
Fom-A'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
H142-3H5'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
GP-3'CL, ANTI-ERYTHROCYTE
126GH'CL, ANTI-THYROID PEROXIDASE (TPO)
Z116VH4'CL, CD20
TNF-A1'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
HuVHLYS'CL, ANTI-LYSOZYME HYBRIDOMA
AF14, ANTI-ANTI-IDIOTYPIC, I.E. ANTI-E5.2 (AN ANTI-D1.3 WHICH IS ANTI-HEN EGG LYSOZYME), WITH KA (FAB E5.2) = 1.0 X 10EXP9 M AND KA (HEN EGG LYSOZYME) = 1.8 X 10EXP6 M
Vh REN'CL, ANTI-CARDIOLIPIN/BETA 2 GLYCOPROTEIN I AUTOANTIBODY
MRK16'CL, ANTI-MULTIDRUG TRANSPORTER P-GLYCOPROTEIN
slkv14'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
QC1'CL, ANTI-CHROMATIN
3374, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
MP10'CL, ANTI-HLA CLASS II (DRB1*01,*09,*1001,*15,*16)
anti-(cyd-1)'CL, ANTI-(CYD-1)
KAS, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
f'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
4G12'CL, ANTI-MALIGNANT TUMOR, BROAD SPECIFICITY ESPECIALLY FOR LUNG SQUAMOUS CELL CARCINOMA, HYBRIDOMA
ALN/12/88'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
L3'CL, ANTI-HEN EGG WHITE LYSOZYME
WAT'CL, RHEUMATOID FACTOR
BBLC107.5'CL, ANTI-BACTERIAL LEVAN
H152-43B2'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
AZ-14'CL, CATALYTIC ANTIBODY
RF9-12'CL, ANTI-IGG2A
I13'CL, ANTI-RH(D)
cAbCA10, ANTI-CARBONIC ANHYDRASE
1-12'CL, ANTI-SM HYBRIDOMA
SO2'CL, ANTI9-HLA-DQ3
N901L/KOL, ANTI-CD56
126IK'CL, ANTI-THYROID PEROXIDASE (TPO)
UN34.11'CL, ANTI-TC,ANTI-RBC
RF-MR27'CL, RHEUMATOID FACTOR
HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME
RF6-6A'CL, ANTI-IGG1
163.22, ANTI-P53
2INH5'CL, ANTI-HUMAN INSULIN
heavy3'CL, ANTI-HUMAN THYROGLOBULIN
BS-1, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
pMDABG2-4'CL, ANTI-HEMAGGLUTININ
13F1'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
H35-C10'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
126TO6H'CL, ANTI-THYROID PEROXIDASE (TPO)
S2P10'CL, RHEUMATOID FACTOR
LN2 7'CL, ANTI-MOUSE TYPE II COLLAGEN
hsiggll150'CL, ANTI-RABBIT IGG
7B6''CL, ANTI-SM HYBRIDOMA
RF-SJ1'CL, RHEUMATOID FACTOR AUTOANTIBODY
306'CL, ANTI-INSULIN
60.3'CL, ANTI-CD18
OX-34, ANTI-RAT CD2
hu2.10, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
T10-352'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
mAb49'CL, ANTI-INSULIN
VS3, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
VH iv.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
T10-440'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
14D2.D6'CL, ANTI-RAT 62 CYTOCHROME C
MF8 (Humkv328-Jk1)'CL, RHEUMATOID FACTOR
DPA'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
slkv15'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
C25'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 2 (KD = 1.1 X 10EXP-9)
10VA2'CL, AUTOANTIBODY TO THYROGLOBULIN
scFv 1F9'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
3T72, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
K1, ANTI-MESOTHELIN
LG2-1'CL, ANTI-BOVINE THYMUS HISTONES (H3 RES. 30-45)
13G12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
heavy4'CL, ANTI-HUMAN THYROGLOBULIN
VH A121, ANTI-CD34
3368, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
D16'CL, ANTI-RH(D)
2INL1'CL, ANTI-HUMAN INSULIN
2F8.C10'CL, ANTI-RAT 44 CYTOCHROME C
R5A3H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
546'CL, ANTI-P601E
H230-5'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
LA1L1'CL, RHEUMATOID FACTOR
M56'CL, ANTI-SMITH ANTIGEN HYBRIDOMA
FV-BETA, ANTI-HCG
Z55VH3'CL, CD20
24.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
bkv32'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
H147-25H1'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
D11'CL, ANTI-RH(D)
CP4 9-9'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
MRA12H'CL, ANTI-HISTONE
MRL-Histone7'CL, ANTI-HISTONE 2A,4 HYBRIDOMA
2INL16'CL, ANTI-HUMAN INSULIN
RF-IP18'CL, RHEUMATOID FACTOR
TR1.37'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
CBLC213.7'CL, ANTI-BACTERIAL LEVAN
CL-P'CL, ANTI-ERYTHROCYTE
BBLC44.1'CL, ANTI-BACTERIAL LEVAN
hsiglvp1213'CL, ANTI-RABBIT IGG
301'CL, ANTI-INSULIN
RC1H, LOW AFFINITY POLYREACTIVE (ANTI-FC,ANTI-TETANUS TOXOID,ANTI-RABBIT IGG, ANTI-SSDNA) RHEUMATOID FACTOR (RF)
4A6 Fab'CL, ANTI-RECOMBINANT BIRCH PROFILIN
#21'CL, ANTI-LA RNP (RIBONUCLEOPROTEIN)
E66, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
A26'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
G21'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
2E11'CL, CATALYTIC ANTIBODY
JV8'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
MRB4'CL, ANTI-NUCLEOSOME
RF-SJ2'CL, RHEUMATOID FACTOR AUTOANTIBODY
CBGA1'CL, POLY-REACTIVE INCLUDING PSEUDOMONAS AERUGINOSA PA C7-67, ESCHERICHIA COLI O1Z, ERYTHROCYTES FROM DONOR, ETC.
RB4v1.2, ANTI-CD19
9E10'CL, ANTI-C MYC
AC41'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
BrM8'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
FS-3'CL, COLD AGGLUTININ
E225'CL, ANTI-D1.3 MAB
IM9, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
48.2.1'CL, ANTI-IDIOTYPIC ANTIBODY
B27'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 1.5 X 10EXP-6)
H140-1E6'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
Ab21'CL, POLYREACTIVE AUTOANTIBODY
slkv16'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
mAb A41'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
heavy5'CL, ANTI-HUMAN THYROGLOBULIN
RF-5'CL, ANTI-IGG1 RHEUMATOID FACTOR
CP4 12-18'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
10/14'CL, ANTI-MONOCLONAL ANTIIDIOTYPIC ANTIBODY IDA10 HYBRIDOMA
L17'CL, AUTOANTIBODY
208,D-5, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
MAB61'CL, KIM11.4
1G3.E3'CL, ANTI-COW 44 CYTOCHROME C
SP2'CL, ANTI-HUMAN THYROID PEROXIDASE
lambda5'CL, ANTI-HUMAN THYROGLOBULIN
HuVK'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
112'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
BBLC259.11'CL, ANTI-BACTERIAL LEVAN
ASWA2'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
KJ16'CL, ANTI-TCR VB8.1 & VB8.2
HA-7'CL, ANTI-ERYTHROCYTE
JV3'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
RF-SJ3'CL, RHEUMATOID FACTOR AUTOANTIBODY
S25'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 1 (KD = 7.3 X 10EXP-8)
126DH'CL, ANTI-THYROID PEROXIDASE (TPO)
s6C9'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
126.33'CL, ANTI-B1335 DEX
S2-14.2'CL, ANTI-TC,ANTI-RBC
M2 136'CL, ANTI-MOUSE TYPE II COLLAGEN
CE10G11G2'CL, ANTI-P34
TB-1-P5'CL, RHEUMATOID FACTOR
16E4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
TR1.21'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
D3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
26C1'CL, ANTI-RH(D)
126TO8H'CL, ANTI-THYROID PEROXIDASE (TPO)
4A11'CL, ANTI-P601E
L2,5'CL, ANTI-HEN EGG WHITE LYSOZYME
T8-3'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
BBLC508.17'CL, ANTI-BACTERIAL LEVAN
C01'CL, ANTI-RH(D)
GB4v2.3, ANTI-CD19
431'CL, ANTI-P601E
T8-203'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
Pag-1'CL, ANTI-D ANTIGEN OF THE RH-BLOOD GROUP SYSTEM
CB 379'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
cDNA2-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
HYHEL-8, ANTI-HEN EGG WHITE LYSOZYME
mAb 133'CL, ANTI-INSULIN
H20C3K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
WG3'CL, ANTI-PROTEINASE 3
126FK'CL, ANTI-THYROID PEROXIDASE (TPO)
HUL-GL'CL, ANTI-IGG (RHEUMATOID FACTOR)
18.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
L11-2E2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
417.F33.3'CL, MONOREACTIVE
TR1.22'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
5-3'CL, ANTI-IGG2A
126TO9H'CL, ANTI-THYROID PEROXIDASE (TPO)
F1_1471'CL, ANTI-FRACTION 1
TEL9'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
CLONE 1C4'CL, ANTI-HUMAN RED BLOOD CELL
m62N/D, ANTI-IDIOTYPIC
KOL-based resh. CAMPATH-9, ANTI-HUMAN CD4
A4, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
L03'CL, ANTI-RH(D)
22F6'CL, ANTI-SM HYBRIDOMA
C595, ANTI-(MUC1 MUCIN)
CB 313'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
417.F25'CL, POLYREACTIVE
1B6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
LS6'CL, ANTI-PR2 RBC AUTOANTIBODY
8H9D4'CL, ANTI-PLASMINOGEN ACTIVATOR INHIBITOR-1 (BY SWITCHING THE INHIBITORY CONFORMATION TO A SUBSTRATE CONFORMATION)
HuMAb22-13'CL, ANTI-LUNG TUMOR-ASSOCIATED ANTIGEN
RF-KES'CL, MONOREACTIVE RHEUMATOID FACTOR
m32,33, ANTI-IDIOTYPIC
1D7'CL, ANTI-HUMAN APOLIPOPROTEIN E (SPECIFIC FOR THE LOW DENSITY LIPOPROTEIN RECEPTOR-BINDING SITE)
28/12'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
F1_1254'CL, ANTI-FRACTION 1
VS4'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
VH A47, ANTI-CD34
K.Kpb1'CL, ANTI-KP B
VH A30, ANTI-CD34
RF1-7K'CL, ANTI-IGG1
H02, ANTI-LYSOZYME HYBRIDOMA
C11'CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=5.8X10EXP8)
M37GO37'CL, ANTI-E2 COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
5E4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
A003=40/5G7'CL, ANTI-BLOOD GROUP A SUBSTANCE HYBRIDOMA
7E10'CL, ANTI-SM HYBRIDOMA
TR1.23'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
A34'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
TR1.5'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
WRD6'CL, RHEUMATOID FACTOR
LS1'CL, ANTI-PR2 RBC AUTOANTIBODY
F29'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
E01'CL, ANTI-RH(D)
CLONE 1F7'CL, ANTI-HUMAN RED BLOOD CELL
VL G61'CL, ANTI-GLUTATHIONE S-TRANSFERASE
418.F63.35'CL, POLYREACTIVE
MR-1'CL, ANTI-MURINE GP39
MRA5H'CL, ANTI-HISTONE
C05, ANTI-LYSOZYME HYBRIDOMA
UN42.5'CL, ANTI-TC,ANTI-RBC
N901L/KV2F, ANTI-CD56
MRA12K'CL, ANTI-HISTONE
3-31'CL, ANTI-SM HYBRIDOMA
4.16.1'CL, ANTI-MOUSE ERYTHROCYTE AUTOANTIBODY
1G5'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
E38, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
WEI', CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
E225, ANTI-D1.3 HYBRIDOMA
THY-29'CL, ANTI-HUMAN THYROGLOBULIN
CP5 B5-3'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
H37-40'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
alpha-poxn2, ANTI-POXN
L1'CL, ANTI-HEN EGG WHITE LYSOZYME
HUMANIZED YFC51.1'CL, ANTI-HUMAN CD18
3C8H'CL, ANTI-MURINE SERUM ALBUMIN
TUR, COLD AGGLUTININ WITH ANTI-PR ACTIVITY
D10, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
31-9D'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
scFv-KJ16 mut4'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
Hb-4, ANTI-FOETAL HAEMOGLOBIN (HBF)
G01'CL, ANTI-RH(D)
17F12'CL, ANTI-HUMAN IGG
2.7.1G.10'CL, ANTI-CARCINOEMBRYONIC ANTIGEN HYBRIDOMA
1E6'CL, ANTI-HUMAN PROCOLLAGENASE
2677.1'CL, ANTI-BACTERIAL LEVAN
JV10'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
F1_1352'CL, ANTI-FRACTION 1
TB-2-H70'CL, RHEUMATOID FACTOR
333'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 BEFORE TREATMENT WITH 7D11.
Y19-10'CL, ANTI-IGG HYBRIDOMA
C2'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
AD9'CL, ANTI-ERYTHROCYTE RH(D) 
I06'CL, ANTI-RH(D)
D3'CL, ANTI-MOUSE TYPE II COLLAGEN
RF6-2'CL, ANTI-IGG2A
9F12Fab'CL, ANTI-TETANUS TOXIN
T10-505'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
MP14'CL, ANTI-HLA CLASS II (DRB1*08,*12)
3D7.2'CL, ANTI-CHROMATIN
Resurfaced Anti-B4, ANTI-CD19
E8'CL, ANTI-HORSE CYTOCHROME C
RF10-2'CL, ANTI-IGG2A
alphaGPIIIa leu 33'CL, ANTI-LEUCINE-33 FORM OF PLATELET GLYCOPROTEIN IIIA
MRA7K'CL, ANTI-HISTONE
GOL', HUMAN MONOCLONAL ANTIBODY WITH WA IDIOTYPE
RF9-5'CL, ANTI-IGG2A
Fom-1'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
126AH'CL, ANTI-THYROID PEROXIDASE (TPO)
MP6'CL, ANTI-HLA CLASS I (A*3002)
clone 14'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
M2 139'CL, ANTI-MOUSE TYPE II COLLAGEN
RF1-7M'CL, ANTI-IGG1
AC32'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
LUNm01'CL, ANTI-CLASS 5C OUTER MEMBRANE PROTEIN OF NEISSERIA MENINGITIDIS
B12'CL, ANTI-IDIOTYPE OF THE MURINE MAB RSV19
126CK'CL, ANTI-THYROID PEROXIDASE (TPO)
CLONE 1C9'CL, ANTI-HUMAN RED BLOOD CELL
MSL5, ANTI-LEWIS Y
3-69'CL, ANTI-SM HYBRIDOMA
9-3'CL, ANTI-IGG2A
73.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
L33'CL, AUTOANTIBODY
CG-7'CL, ANTI-ERYTHROCYTE
1E8'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
22.218.1'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
RF1-2'CL, ANTI-IGG2A
Z30VH3'CL, CD20
HA-4'CL, ANTI-ERYTHROCYTE
I01'CL, ANTI-RH(D)
ATM-2, ANTI-TCR VBETA
2C3'CL, ANTI-HUMAN PROCOLLAGENASE
LN2 97'CL, ANTI-MOUSE TYPE II COLLAGEN
106-10E'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
AC7'CL, ANTI-RGD (ARG-GLY-ASP) BINDING SITE ON THE GPIIIA SUBUNIT OF THE PLATELET FIBRINOGEN RECEPTOR, THE GPIIB-GPIIIA COMPLEX
MRL-RF24'CL, ANTI-IGG1,2A,3 HYBRIDOMA
RF3-4'CL, ANTI-IGG2A
ANTI-LEU3a'CL, ANTI-HUMAN CD4
HIG1, ANTI-ACHR
HP20'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
WR1.107'CL, ANTI-THYROID PEROXIDASE
22'CL, ANTI-INSULIN
F5-1336'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
lambda4'CL, ANTI-HUMAN THYROGLOBULIN
18'CL, ANTI-P601E
PE24'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
131TP2H'CL, ANTI-THYROID PEROXIDASE (TPO)
98QQ'CL, ANTI-3,5,3'-TRIIODO-L-THRYRONINE COUPLED KEYHOLE LIMPET HEMOCYANIN
My10, ANTI-HUMAN CD34 (KD = 2.4 X 10EXP-7 M)
126TO10K'CL, ANTI-THYROID PEROXIDASE (TPO)
2H12'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
slkv4'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
3-19'CL, ANTI-SM HYBRIDOMA
DPK24, ANTI-P53
D09'CL, ANTI-RH(D)
hsiglvl295'CL, ANTI-RABBIT IGG
G05, ANTI-LYSOZYME HYBRIDOMA
SON, CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
147'CL, ANTI-P601E
RF-KL1'CL, RHEUMATOID FACTOR AUTOANTIBODY
slkv9'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
E14, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
PA4'CL, ANTI-CHROMATIN
2-4'CL, ANTI-SM HYBRIDOMA
D2'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST THE THYROTROPIN (TSH) RECEPTOR
B/SB5-7'CL, ANTI-H2A/H2B
AP1'CL, ANTI-GLYCOPHORIN A
TB-3-D13'CL, RHEUMATOID FACTOR
G4, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
JAC-1, ANTI-POLYAMINE, CROSS REACTS WITH SPERMINE
24'CL, ANTI-LE X, SIALYL LE X
FOG1-H6'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
COF'CL, RHEUMATOID FACTOR
Z48VH3'CL, CD20
6E5'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 1X10EXP-8)
D04'CL, ANTI-RH(D)
3.14.9'CL, ANTI-LEVAN
IM9-2, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
PE1'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 187GGFMRG192
E4-14'CL, ANTI-CON A
RF-1''CL, ANTI-IGG3 RHEUMATOID FACTOR
pVCM(VD93)'CL, ANTI-PSEUDOMONAS AERUGINOSA HYBRIDOMA
93.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
G6, ANTI-MESOTHELIN
A4'CL, ANTI-GLYCOPHORIN A
K01'CL, ANTI-RH(D)
TNF-E1'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
HA-10'CL, ANTI-ERYTHROCYTE
HUMHA4114'CL, KIM11.4
B22'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 6.0 X 10EXP-5)
VL G64'CL, ANTI-GLUTATHIONE S-TRANSFERASE
mAb 127'CL, ANTI-INSULIN HYBRIDOMA
T6-416'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
17-1A'CL, ANTI-SW1083 COLORECTAL CARCINOMA CELL HYBRIDOMA
H36-2'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
C2'CL, ANTI-MOUSE TYPE II COLLAGEN
F5-444'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
AC38 205.12, ANTIBODY AC38-POSITIVE HYBRIDOMA
RF3-2CR2A'CL, ANTI-IGG2A
F28C4'CL, ANTI-MYELINE BASIC PROTEIN, ACETYL RESIDUES 1-9
AC-1001'CL, ANTI-BLOOD GROUP A SUBSTANCE HYBRIDOMA
Z97VH3'CL, CD20
FOG1-A4'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
mAb10'CL, POLYREACTIVE AUTOANTIBODY
H37-43'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
5D9'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
2INH4'CL, ANTI-HUMAN INSULIN
mAb48'CL, ANTI-INSULIN
E63, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
HA-5'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
RF-TT1'CL, RHEUMATOID FACTOR
PE18'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
Hb-1, ANTI-FOETAL HAEMOGLOBIN (HBF)
2BBLC403.4'CL, ANTI-BACTERIAL LEVAN
K20'CL, ANTI-BETA 1 CHAIN OF HUMAN INTEGRIN
FV/IL-2'CL, ANTI-TAG72
F4-23'CL, ANTI-CON A
B03, ANTI-LYSOZYME HYBRIDOMA
L41'CL, AUTOANTIBODY
RA-4-Pd2'CL, RHEUMATOID FACTOR
2-11'CL, ANTI-SM HYBRIDOMA
R6B8H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
5E1'CL, ANTI-HUMAN PROCOLLAGENASE
CL-J'CL, ANTI-ERYTHROCYTE
M16'CL, ANTI-HUMAN INSULIN
A28A'CL, ANTI-IGG2A
mAb61'CL, MONOREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
126TP15H'CL, ANTI-THYROID PEROXIDASE (TPO)
RF-2 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
37-77'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
M-T151'CL, ANTI-HUMAN CD4
D08, ANTI-LYSOZYME HYBRIDOMA
TB-3-D6'CL, RHEUMATOID FACTOR
B'20H, POLYREACTIVE (HIGH AFFINITY ANTI-HUMAN FC AND LOW AFFINITY ANTI-RABBIT IGG, ANTI-SSDNA, ANTI-TETANUS TOXOID) RHEUMATOID FACTOR (RF)
clone 1,3-12'CL, ANTI-F(AB')2 AUTOANTIBODY (BINDING CONSTANT=2.8X10EXP7)
IC5-2A6'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
Ab2022'CL, ANTI-INSULIN AUTOANTIBODY
25G05, ANTI-LYSOZYME HYBRIDOMA
1-9'CL, ANTI-IGG2A
4-35-7'CL, ANTI-HLA-A1, A23 AND A24
cAbAMB10, ANTI-ALPHA-AMYLASE
E13'CL, ANTI-MELANOMA
H81'CL, ANTI-LAMININ
LL2'CL, ANTI-CD22, A SURFACE MOLECULE PRESENT ON B CELL LYMPHOMA
302'CL, ANTI-INSULIN
DPB'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
D2'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
CB 300'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
D17'CL, ANTI-RH(D)
MRA11H'CL, ANTI-HISTONE
B/SB5-33'CL, ANTI-H2A/H2B
cAb-Lys3, ANTI-LYSOZYME
BS-5, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
C9'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
TR1.10'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
RF51'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
HA-1'CL, ANTI-ERYTHROCYTE
S/SB5-84'CL, ANTI-H4
A1'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
AH7'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
B4.13.2'CL, ANTI-MOUSE ERYTHROCYTE AUTOANTIBODY
JV9'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
S1P1'CL, RHEUMATOID FACTOR
cAbAMD9, ANTI-ALPHA-AMYLASE
RF10-4K'CL, ANTI-IGG2A
alpha-poxn4, ANTI-POXN
VHTF'CL, ANTI-PORCINE TRANSFERRIN
mH-M, ANTI-IDIOTYPIC
B/SB5-37'CL, ANTI-H4
H 113'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
Hu PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
O01'CL, ANTI-RH(D)
A12', ANTI-LYSOZYME HYBRIDOMA
GAR', CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
18R.136.1'CL, CATALYTIC ANTIBODY
TT125'CL, ANTI-TETANUS TOXIN, TOXOID AND A FRAGMENT (LIGHT CHAIN) OF TETANUS TOXIN
RF-TS5'CL, MONOREACTIVE RHEUMATOID FACTOR
2D9H'CL, ANTI-MURINE SERUM ALBUMIN
K1 like, ANTI-MESOTHELIN-POSITIVE CELLS
BOR', ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
LN2 173'CL, ANTI-MOUSE TYPE II COLLAGEN
JV4'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
3A10'CL, ANTI-P601E
B9601 (Vg-Jk2)'CL, RHEUMATOID FACTOR
H3, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
Jel42'CL, ANTI-ESCHERICHIA COLI HISTIDINE-CONTAINING PROTEIN (HPR)
131TP5H'CL, ANTI-THYROID PEROXIDASE (TPO)
2E8'CL, ANTI-HUMAN APOLIPOPROTEIN E (SPECIFIC FOR THE LOW DENSITY LIPOPROTEIN RECEPTOR-BINDING SITE)
RF-TT3'CL, RHEUMATOID FACTOR
cAbAM04, ANTI-ALPHA-AMYLASE
H220-10'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
L3G11'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
IC5-4F4'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
H17-L19'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
BrE-3'CL, ANTI-HUMAN BREAST EPITHELIAL MUCIN
E67, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
Mik-B1(Fv)-PE40'CL, ANTI-INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
500A2'CL, ANTI-MURINE CD3
J04'CL, ANTI-RH(D)
4-6-2'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
163.14, ANTI-P53
RF-IP16'CL, RHEUMATOID FACTOR
E26'CL, ANTI-MELANOMA
RF49A, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
36-7'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
P11'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 1.6 X 10EXP-6), ANTI-PROTHROMBIN (KD = 3.2 X 10EXP-6)
CLONE 1D2'CL, ANTI-HUMAN RED BLOOD CELL
1F4'CL, ANTI-IDIOTOPE OF 4-4-20
F12, ANTI-MESOTHELIN
D98, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
L32'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
417.F1.1.35'CL, MONOREACTIVE
H146-24B3'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
cDNA1-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
T10-1'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
MA-15C5'CL, ANTI-HUMAN FIBRIN FRAGMENT D-DIMER
N92'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
D9D10'CL, ANTI-HUMAN INTERFERON-GAMMA
KO3-34'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
DAUDI, ANTI-ACHR
3381, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
16.3'CL, ANTI-B1335 DEX
OKT3 scFv'CL, ANTI-HUMAN CD3 EPSILON
D7.4'CL, AUTOANTI-IDIOTYPIC MAB TO ANTI-DNA MAB A52(IGG2B-KAPPA)
4422, ANTI-TYPE II PNEUMOCOCCAL POLYSACCHARIDE
hsiglvl962'CL, ANTI-RABBIT IGG
HuNMVH'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
PIE, AUTOANTIBODY WHICH BINDS SPECIFICALLY TO INTERMEDIATE FILAMENTS
DR12910-2F8'CL, ANTI-DR 1,2,9,10 HYBRIDOMA
T1-107'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
WG4'CL, ANTI-PROTEINASE 3
Q01'CL, ANTI-RH(D)
cAbAMD10, ANTI-ALPHA-AMYLASE
CLONE 42PF'CL, ANTI-LEUCINE ZIPPER
CLONE 1E3'CL, ANTI-HUMAN RED BLOOD CELL
KS13'CL, ANTI-HLA-DQ3
3-4'CL, ANTI-IGG2A
E26, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
GN901v1.0, ANTI-CD56
A28K'CL, ANTI-IGG2A
T4-57'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
3-7'CL, ANTI-SM HYBRIDOMA
CL-G'CL, ANTI-ERYTHROCYTE
BEN-27'CL, ANTI-HISTONE H1 (RESIDUES 204-218)
71.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
262.9'CL, ANTI-B1335 DEX
mAb65'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
SCA, CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
RF6-6K'CL, ANTI-IGG1
T5-131'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
B-33'CL, ANTI-CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR/INSULIN-LIKE GROWTH FACTOR TYPE -2 RECEPTOR
163.15, ANTI-P53
Y2'CL, ANTI-SMALL NUCLEOPROTEIN SM
A06, ANTI-LYSOZYME HYBRIDOMA
3322-B, ANTI-TYPE VIII PNEUMOCOCCAL POLYSACCHARIDE
131TP6H'CL, ANTI-THYROID PEROXIDASE (TPO)
2F7'CL, ANTI-HUMAN PROCOLLAGENASE
TA2'CL, ANTI-TG
PE15'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
28E4'CL, ANTI-RH(D)
cDNA6-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
SM2R2A'CL, ANTI-SM
3E5'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
FS-7'CL, COLD AGGLUTININ
H10''CL, ANTI-LAMININ
RF-2'CL, ANTI-IGG3 RHEUMATOID FACTOR
18B7'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
126HH'CL, ANTI-THYROID PEROXIDASE (TPO)
126'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
L26'CL, AUTOANTIBODY
D8'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
hsiglvl150'CL, ANTI-RABBIT IGG
L04'CL, ANTI-RH(D)
21H9'CL, ANTI-RH(D)
91.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
alpha-poxn5, ANTI-POXN
LS7'CL, ANTI-PR2 RBC AUTOANTIBODY
F5-963'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
CB 20'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
HV1L1'CL, RHEUMATOID FACTOR
cAbCA06, ANTI-CARBONIC ANHYDRASE
HA-2'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
2-2C8'CL, ANTI-BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
Tg10'CL, ANTI-HUMAN THYROGLOBULIN
mAb 126'CL, ANTI-INSULIN HYBRIDOMA
IgG+ CLL'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
131TP7H'CL, ANTI-THYROID PEROXIDASE (TPO)
S01'CL, ANTI-RH(D)
2G7'CL, ANTI-SM HYBRIDOMA
HY18'CL, ANTI-B CELL AUTOANTIBODY
GP-4'CL, ANTI-ERYTHROCYTE
B9'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
SP1.2'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
ASWA1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8 AND FIBRILLARIN
AZ-42'CL, CATALYTIC ANTIBODY
69.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
TB-1-M2'CL, RHEUMATOID FACTOR
POR'CL, ANTI-FC IGG
2G4'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
B72.3'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
RF-TT5'CL, RHEUMATOID FACTOR
H17-L7'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
LS2'CL, ANTI-PR2 RBC AUTOANTIBODY
20.119.25'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID20 HYBRIDOMA
2-2G4'CL, ANTI-BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
H120-2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
T1'CL, ANTI-HEN BOVINE THYROGLOBULIN
6F'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
163.2, ANTI-P53
N901H/G36005, ANTI-CD56
FOG1-A3'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
M5'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
F4-3'CL, ANTI-CON A
H11'CL, CATALYTIC ANTIBODY WHICH CATALYSES A DIELS-ALDER CYCLOADDITION REACTION
HP27'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
MRA11K'CL, ANTI-HISTONE
Fab clone 1, ANTI-RYE-GRASS POLLEN ALLERGEN (KD = 2.63 X 10EXP-9 M)
B/SB5-28'CL, ANTI-H2A/H2B
F1_1252'CL, ANTI-FRACTION 1
ABO.HI1'CL, ANTI-HI
4F7'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 4X10EXP-8)
HIC5-4D1'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
B72.3-1-3'CL, ANTI-TAG72
A2, ANTI-MESOTHELIN
RF3-2CR2K'CL, ANTI-IGG2A
MN12H2'CL, ANTI-OUTER MEMBRANE PROTEIN PORA OF NEISSERIA MENINGITIDIS
H37-80'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
VH G61'CL, ANTI-GLUTATHIONE S-TRANSFERASE
TR1.9'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
MD11'CL, ANTI-TETANUS TOXOID
E3G6'CL, ANTI-GLYCOPROTEIN (GP) IA/IIA
H152-42A3'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
2B12B3'CL, ANTI-DER P 2  (HOUSE DUST MITE ALLERGEN)
126TP14H'CL, ANTI-THYROID PEROXIDASE (TPO)
2E8'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
163.7, ANTI-P53
46E7'CL, ANTI-RH(D)
CB0010, ANTI-RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR-ALPHA
409'CL, ANTI-P601E
CLONE 1E8'CL, ANTI-HUMAN RED BLOOD CELL
131TP8H'CL, ANTI-THYROID PEROXIDASE (TPO)
CG-1'CL, ANTI-ERYTHROCYTE
HUMLA1114'CL, KIM11.4
VL G69'CL, ANTI-GLUTATHIONE S-TRANSFERASE
AD14'CL, ANTI-ERYTHROCYTE RH(D) 
Ery.X1'CL, PANAGGLUTININ
126TP1K'CL, ANTI-THYROID PEROXIDASE (TPO)
131'CL, ANTI-ANGIOTENSION II; ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST MONOCLONAL ANTIBODY 110
10-2'CL, ANTI-IGG2A
80.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
F3, ANTI-MESOTHELIN
RF-MR24'CL, RHEUMATOID FACTOR
ATM-1, ANTI-TCR VBETA
M182'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
89.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
HPC4, ANTI-HUMAN PROTEIN C
3C8L'CL, ANTI-MURINE SERUM ALBUMIN
VH6-19'CL, ANTI-IGG2A RHEUMATOID FACTOR
LV1L1'CL, RHEUMATOID FACTOR
38C13'CL, ANTI-IDIOTYPIC ANTIBODY HYBRIDOMA
163.17, ANTI-P53
X3'CL, ANTI-HUMAN INTERLEUKIN-1 ALPHA
36-4'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
SS629, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
LN2 121'CL, ANTI-MOUSE TYPE II COLLAGEN
93-6'CL, ANTI-BETA-SUBUNIT OF ESCHERICHIA COLI TRYPTOPHAN SYNTHETASE (BINDING CONSTANT=6.7XEXP9)
L39'CL, AUTOANTIBODY
I07'CL, ANTI-RH(D)
EL-16'CL, ANTI-FACTOR VIII
FS-4'CL, COLD AGGLUTININ
2-2'CL, ANTI-IGG2A
WRI-170'CL, ANTI-HISTONE H1 (RESIDUES 1-16 AND 204-218)
VL ii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
FV-ALPHA, ANTI-HCG
L34'CL, AUTOANTIBODY
I02'CL, ANTI-RH(D)
Ab44'CL, POLYREACTIVE AUTOANTIBODY
RF2-2'CL, ANTI-IGG2A
HA-RI'CL, ANTI-ERYTHROCYTE
A9A7'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
RF4-4'CL, ANTI-IGG2A
E47, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
81D2'CL, AUTOANTIBODY TO THYROGLOBULIN
AD5/16'CL, ANTI-ERYTHROCYTE RH(D) 
RF5-5'CL, ANTI-IGG2A
Z36VH4'CL, CD20
Z85VH3'CL, CD20
slkv3'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
KC4G3'CL, ANTI-HUMAN BREAST MUCIN (AFFINITY CONSTANT=1.1X10EXP9)
H3, ANTI-MESOTHELIN
CL-D'CL, ANTI-ERYTHROCYTE
1H4'CL, ANTI-CD20
416.F2.2.34'CL, POLYREACTIVE
RF2-7'CL, ANTI-IGG2A
TNF-E7'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
B14'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 7.0 X 10EXP-5)
1A6'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
C8'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
2B9H'CL, ANTI-MURINE SERUM ALBUMIN
NEW-based resh. CAMPATH-9, ANTI-HUMAN CD4
126TP2K'CL, ANTI-THYROID PEROXIDASE (TPO)
GP-1'CL, ANTI-ERYTHROCYTE
E42, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
HuVH'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (LOW AFFINITY)
hsighvm148'CL, ANTI-BETA-AMYLOID
RF-IP15'CL, RHEUMATOID FACTOR
RF-SJ5'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
L2-10CL'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
1C6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 3 (KD = 2.0 X 10EXP-8)
RF1-6'CL, ANTI-IGG2A
HUC'CL, ANTI-SM
mAb426.4.2F20'CL, POLYREACTIVE AUTOANTIBODY
HA-8'CL, ANTI-ERYTHROCYTE
7'CL, ANTI-INSULIN
HuKLVH'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
ASWU1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
1-10'CL, ANTI-SM HYBRIDOMA
E6'CL, ANTI-HUMAN TRANSFERRIN RECEPTOR
H37-82'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
207,B-4, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
Z31VH4'CL, CD20
VL iii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
4G11'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST THE THYROTROPIN (TSH) RECEPTOR
D05'CL, ANTI-RH(D)
39D10, HUMAN IL-5
3F10'CL, ANTI-HUMAN PROCOLLAGENASE
DP-50'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
B-24'CL, ANTI-CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR/INSULIN-LIKE GROWTH FACTOR TYPE -2 RECEPTOR
7-13'CL, ANTI-SM HYBRIDOMA
lambda2'CL, ANTI-HUMAN THYROGLOBULIN
BBLC434.22'CL, ANTI-BACTERIAL LEVAN
HG2B10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
SO4'CL, ANTI9-HLA-DQ3
126GK'CL, ANTI-THYROID PEROXIDASE (TPO)
1G1.E9'CL, ANTI-HORSE 44/47 CYTOCHROME C
RFT2'CL, ANTI-CD7
K02'CL, ANTI-RH(D)
Z26'CL, ANTI-SMITH ANTIGEN HYBRIDOMA
TB-2-H68'CL, RHEUMATOID FACTOR
AZ-12'CL, CATALYTIC ANTIBODY
L3 11D'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
H2'CL, ANTI-HUMAN LIVER CELLS
3H4'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
H230-7'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
E2''CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=6.8X10EXP8)
2INH3'CL, ANTI-HUMAN INSULIN
ALN/17/172'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
110'CL, ANTI-KEY HOLE LIMPET HEMOCYANIN-COUPLED ANGIOTENSIN II
C9'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
HuVHNA'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (MEDIUM AFFINITY)
16.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
9F11'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
KOL, ANTI-CD56
YFC51.1'CL, ANTI-HUMAN CD18
126TP15K'CL, ANTI-THYROID PEROXIDASE (TPO)
HYHEL-5, ANTI-HEN EGG WHITE LYSOZYME
M02'CL, ANTI-RH(D)
I10'CL, ANTI-RH(D)
cAbCA05, ANTI-CARBONIC ANHYDRASE
2INH8'CL, ANTI-HUMAN INSULIN
B7'CL, ANTI-HUMAN CARDIAC MYOSIN
D18'CL, ANTI-RH(D)
A7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
PR1(FV)-PE38KDEL'CL, ANTI-PR1 ANTIGEN ON HUMAN PROSTATE CANCER CELLS AND NORMAL PROSTATE TISSUE
OVA'CL, ANTI-CHICKEN OVALBUMIN
12ICI'CL, AUTOANTIBODY TO THYROGLOBULIN
F(ab)-12, ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
A15'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
17E12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
PR-TS1'CL, POLYREACTIVE RHEUMATOID FACTOR
D6'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
GB4v2.0, ANTI-CD19
RA-3-A3.2'CL, RHEUMATOID FACTOR
HUNVK'CL, ANTI-MYELIN ASSOCIATED PROTEIN
6-2'CL, ANTI-IGG2A
DSC, ANTI-IDIOTYPIC
126TO15H'CL, ANTI-THYROID PEROXIDASE (TPO)
AC21B'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
E50, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
VH G64'CL, ANTI-GLUTATHIONE S-TRANSFERASE
mAb 125'CL, ANTI-INSULIN HYBRIDOMA
CH31'CL, ANTI-E. COLI
a'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
E19, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
25G09, ANTI-LYSOZYME HYBRIDOMA
IE12'CL, ANTI-F(AB')2
mAb60'CL, MONOREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
A4.6.1, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
CB 340'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
RF-TT9'CL, RHEUMATOID FACTOR
B'2 (Humkv328-Jk1)'CL, RHEUMATOID FACTOR
S12M1'CL, ANTI-BROMELAIN-TREATED MOUSE RBC, SHEEP RBC, TRIMETHYLAMMONIUM HYBRIDOMA
D13'CL, ANTI-RH(D)
67.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
LG8-1'CL, ANTI-NUCLEOSOME
bkv17'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
A9'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
B9601 (VH3-JH3)'CL, RHEUMATOID FACTOR
25G12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
2INL4'CL, ANTI-HUMAN INSULIN
MRA10H'CL, ANTI-HISTONE
14C10'CL, ANTI-SM HYBRIDOMA
36-1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
bkv35'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
2INL9'CL, ANTI-HUMAN INSULIN
CLONE pMEK1HC'CL, ANTI-HLA-DR ANTIGENS
Og-31'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
417.F22'CL, POLYREACTIVE
K1B12L'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
G28'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
8-2'CL, ANTI-IGG2A
HuMc3, ANTI-BA46 (A 46-KDA GLYCOPROTEIN OF THE HUMAN MILK FAT GLOBULE MEMBRANE EXPRESSED IN BREAST CARCINOMA CELLS)
H37-84'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
1F6'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
O02'CL, ANTI-RH(D)
RF-3'CL, ANTI-IGG1 RHEUMATOID FACTOR
56R-3'CL, ANTI-3M-1
c'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
OX26'CL, ANTI-RAT TRANSFERRIN RECEPTOR
4H5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
R5A3K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
mAb111'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
RN90v1.1, ANTI-CD56
Hb-5, ANTI-FOETAL HAEMOGLOBIN (HBF)
WAG'CL, RHEUMATOID FACTOR
L34'CL, ANTI-HUMAN CD4
hsiglvl1189'CL, ANTI-RABBIT IGG
22G12'CL, ANTI-SM HYBRIDOMA
126TP5K'CL, ANTI-THYROID PEROXIDASE (TPO)
JV5'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
126TP13H'CL, ANTI-THYROID PEROXIDASE (TPO)
87.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
126BH'CL, ANTI-THYROID PEROXIDASE (TPO)
Di62'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
RF-SB1'CL, RHEUMATOID FACTOR
B/SB5-35'CL, ANTI-H4
A6'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
5H11'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
H250-6'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
1-8'CL, ANTI-SM HYBRIDOMA
L4'CL, ANTI-HEN EGG WHITE LYSOZYME
MabB23'CL, ANTI-HUMAN PLASMA APOLIPOPROTEIN B-100
7-13'CL, ANTI-SM
Humkv305'CL, CROSS-REACTIVE IDIOTYPES ON VK-IGM AUTO-ANTI-IGG
VH BEN'CL, ANTI-LAMIN B AUTOANTIBODY
103-7E'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
RC6 (Vg-Jk5)'CL, RHEUMATOID FACTOR
M7-049'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR ANTI-CEA MAB MA208
C39'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 2 (KD = 2.3 X 10EXP-9)
11/160'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
205.12'CL, ANTI-IDIOTOPE HYBRIDOMA
C08'CL, ANTI-RH(D)
RC6 (VH4.22-JH4)'CL, RHEUMATOID FACTOR
F04, ANTI-LYSOZYME HYBRIDOMA
mAb112'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
LES-C'CL, RHEUMATOID FACTOR
2A1'CL, ANTI-SM HYBRIDOMA
1-10'CL, ANTI-SM
A23'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
HUL-mRF'CL, ANTI-IGG (RHEUMATOID FACTOR)
1C9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
RA-4-Pd18'CL, RHEUMATOID FACTOR
Gad-2'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
H09, ANTI-LYSOZYME HYBRIDOMA
126DK'CL, ANTI-THYROID PEROXIDASE (TPO)
Vk FUR1'CL, ANTI-LAMIN B AUTOANTIBODY
AC11'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
AC33'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
4G9'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
RF-DI1'CL, RHEUMATOID FACTOR
CC92'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
GG48'CL, RHEUMATOID FACTOR
e'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
HP21'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
R1-38'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
C6'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
KA3D1'CL, RHEUMATOID FACTOR
3C6'CL, ANTI-FECAL BACTERIA
TB-3-D91'CL, RHEUMATOID FACTOR
HuVHCAMP'CL, ANTI-HUMAN LYMPHOCYTE HYBRIDOMA
L05'CL, ANTI-RH(D)
RF-IP14'CL, RHEUMATOID FACTOR
H1, ANTI-MESOTHELIN
A07, ANTI-LYSOZYME HYBRIDOMA
cDNA5-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
126TP6K'CL, ANTI-THYROID PEROXIDASE (TPO)
LS8'CL, ANTI-PR2 RBC AUTOANTIBODY
DA4.4/212'CL, ANTI-HUMAN IGM (KA = 3.03 X 10^9 M^-1)
2D9L'CL, ANTI-MURINE SERUM ALBUMIN
B13H4C8'CL, ANTI-MURINE ERYTHROCYTE AUTOANTIBODY
Rh.E1'CL, ANTI-E
RF49'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
21.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
12F4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
GAN4B.5'CL, ANTI-ERYTHROCYTE SURFACE ANTIGEN, RHESUS D
9E10'CL, ANTI-C-MYC
638'CL, ANTI-P601E
L202'CL, ANTI-HUMAN CD4
5-5'CL, ANTI-IGG2A
2F7'CL, ANTI-FECAL BACTERIA
STRAb SA-1A'CL, ANTI-ACTIN/ALPHA-ACTININ AUTOANTIBODY
WRD4'CL, RHEUMATOID FACTOR
mAb113'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
scFv(225.28S)'CL, ANTI-HUMAN HIGH-MOLECULAR WEIGHT MELANOMA-ASSOCIATED ANTIGEN
19B8'CL, ANTI-SM HYBRIDOMA
MRA3H'CL, ANTI-HISTONE
RFB4'CL, ANTI-CD22
E03'CL, ANTI-RH(D)
2-12'CL, ANTI-SM HYBRIDOMA
61.1E9.9'CL, ANTI-IDIOTYPIC ANTIBODY
126TP7K'CL, ANTI-THYROID PEROXIDASE (TPO)
B/SB5-62'CL, ANTI-H2A/H2B
1G7'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
Sulf-1'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
BSA3'CL, ANTI-BOVINE SERUM ALBUMIN
bkv6'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
A02, ANTI-LYSOZYME HYBRIDOMA
1B3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
BIII.136'CL, ANTI-HUMAN BAND 3 PROTEIN CYTOPLASMIC DOMAIN
HUM1V1LI'CL, KIM11.4
M2 84'CL, ANTI-MOUSE TYPE II COLLAGEN
3F4'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
g'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
72.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
RF-DI2'CL, RHEUMATOID FACTOR
E49, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
F5-830'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
VS1'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
S/SB5-41'CL, ANTI-H4
MN14C11.6, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
2BBLC803.1'CL, ANTI-BACTERIAL LEVAN
126TP14K'CL, ANTI-THYROID PEROXIDASE (TPO)
CLONE 1G7'CL, ANTI-HUMAN RED BLOOD CELL
G71'CL, ANTI-MELANOMA
163.6, ANTI-P53
B6.2'CL, ANTI-HUMAN CARCINOMA CELL HYBRIDOMA WHICH REACTS WITH HUMAN BREAST, LUNG AND COLON CARCINOMA
MRA5K'CL, ANTI-HISTONE
RF-IP24'CL, RHEUMATOID FACTOR
L22'CL, AUTOANTIBODY
T5-58'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
cAbCA04, ANTI-CARBONIC ANHYDRASE
TR1.3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
Y13-238 scFv'CL, ANTI-P21 RAS
TB-2-H71'CL, RHEUMATOID FACTOR
H163-130H9'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
26-1'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
163.1, ANTI-P53
B5'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
TR1.8'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
RSP1'CL, ANTI-SM ANTIGEN
PE19'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
53R-1'CL, ANTI-3M-1
lambda1'CL, ANTI-HUMAN THYROGLOBULIN
MRA10K'CL, ANTI-HISTONE
Hb-2, ANTI-FOETAL HAEMOGLOBIN (HBF)
Bip 1'CL, ANTI-BET V 1 (MAJOR BIRCH POLLEN ALLERGEN)
MAb 4C1'CL, ANTI-MAB 1/1
5.M13'CL, AUTOANTIBODY TO THE ACETYLCHOLINE RECEPTOR.
5C9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
417.32.F24.7'CL, MONOREACTIVE
ABO.B1'CL, ANTI-B
COU-1'CL, ANTI-MODIFIED CYTOKERATIN
Sulf-2'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
B1-4'CL, ANTI-HEN BOVINE SERUM ALBUMIN
Bet 2/212'CL, ANTI-MOUSE IGM (KA = 5 X 10^7 M^-1)
LN2 423'CL, ANTI-MOUSE TYPE II COLLAGEN
Reg-A'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
RF-3 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
F1_1259'CL, ANTI-FRACTION 1
Z45VH1'CL, CD20
RF-KL5'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
RF9-3'CL, ANTI-IGG2A
B13'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
5F8.B7'CL, ANTI-HORSE 60 CYTOCHROME C
2-115-58'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR MURINE MONOCLONAL ANTI-ACHR ANTIBODY 63
A8C8'CL, ANTI-TETANUS TOXOID
E07, ANTI-LYSOZYME HYBRIDOMA
62H3'CL, ANTI-HLA-DR RHEUMATOID FACTOR AUTOANTIBODY
126TP8K'CL, ANTI-THYROID PEROXIDASE (TPO)
F5-1126'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
RN901v1.1, ANTI-CD56
T2-150'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
CLONE pMEK1LC'CL, ANTI-HLA-DR ANTIGENS
E10'CL, ANTI-MOUSE TYPE II COLLAGEN
RF7-1'CL, ANTI-IGG2A
126TO1K'CL, ANTI-THYROID PEROXIDASE (TPO)
I08'CL, ANTI-RH(D)
TT117'CL, ANTI-TETANUS TOXIN, TOXOID AND A FRAGMENT (LIGHT CHAIN) OF TETANUS TOXIN
RF8-2'CL, ANTI-IGG2A
AD6'CL, ANTI-ERYTHROCYTE RH(D) 
S5P14'CL, RHEUMATOID FACTOR
9-5'CL, ANTI-IGG2A
GLO, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE; CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
T6-19'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
RF-TS1'CL, RHEUMATOID FACTOR AUTOANTIBODY
D61, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
Z32VH3'CL, CD20
HEW''CL, AUTOANTIBODY
MICA 1'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
EL-9'CL, ANTI-FACTOR VIII
QB1'CL, ANTI-CHROMATIN
81C6'CL, ANTI-TENASCIN
mAb410.7.F91'CL, POLYREACTIVE AUTOANTIBODY
1F3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 4 (KD = 1.2 X 10EXP-8)
m32Y/S, ANTI-IDIOTYPIC
F12'CL, ANTI-DESMOSOME AUTOANTIBODY
2E10'CL, ANTI-SM HYBRIDOMA
12D11'CL, ANTI-SM HYBRIDOMA
CLONE 1C8'CL, ANTI-HUMAN RED BLOOD CELL
E5'CL, ANTI-MOUSE TYPE II COLLAGEN
18F7'CL, ANTI-SM HYBRIDOMA
ITC88'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
B01'CL, ANTI-RH(D)
REGA-3G12'CL, ANTI-NEUTROPHIL GELATINASE B
GOT, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
M2 332'CL, ANTI-MOUSE TYPE II COLLAGEN
A09'CL, ANTI-HUMAN M BLOOD GROUP ANTIGEN
KO3-256'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
85.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
BMA 031-EUCIV2'CL, ANTI-HUMAN T-CELL RECEPTOR HUMANIZED ANTIBODY
C3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
Mad-2'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
L30'CL, AUTOANTIBODY
22.202.16'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
126TP9K'CL, ANTI-THYROID PEROXIDASE (TPO)
CB 239'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
ASWB1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
Sulf-3'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
Fog-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
CEM231.6.7'CL, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN HYBRIDOMA
VH G69'CL, ANTI-GLUTATHIONE S-TRANSFERASE
126TO2K'CL, ANTI-THYROID PEROXIDASE (TPO)
RF-MR5'CL, RHEUMATOID FACTOR
NANUC-2'CL, ANTI-NEUTROPHIL
PE22'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
S/SB5-72'CL, ANTI-H4
6H2.B4'CL, ANTI-RAT 62 CYTOCHROME C
F1_1357'CL, ANTI-FRACTION 1
HuHMFG1'CL, ANTI-HUMAN MUCIN
WRD1'CL, RHEUMATOID FACTOR
C7, ANTI-MESOTHELIN
4A9.D6'CL, ANTI-HORSE 47 CYTOCHROME C
slkv7'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
F1_1260'CL, ANTI-FRACTION 1
MICA 2'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
H36-12'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
VH i.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
Anti-B4, ANTI-CD19
GF4/1.1'CL, ANTI-TETANUS TOXOID
Ab26'CL, POLYREACTIVE AUTOANTIBODY
Id-F2'CL, ANTI-ID FH-6, WHICH IS AN ANTIBODY AGAINST SIALYL SSEA-1
DB3'CL, ANTI-PROGESTERONE HYBRIDOMA
C10, ANTI-LYSOZYME HYBRIDOMA
H37-311'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
kappa1'CL, ANTI-HUMAN THYROGLOBULIN
Z86VH4'CL, CD20
K03'CL, ANTI-RH(D)
S1P15'CL, RHEUMATOID FACTOR
12A1'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
M7-625'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR ANTI-CEA MAB MA208
CC83'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
417.F29'CL, MONOREACTIVE
FS-8'CL, COLD AGGLUTININ
F5-1419'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
E4-12'CL, ANTI-CON A
R1C8K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
clone 2'CL, ANTI-F(AB')2 AUTOANTIBODY
4C11'CL, ANTI-TEPC15 IDIOTYPE ANTIBODY HYBRIDOMA
Sulf-4'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
hsiglvk643'CL, ANTI-RABBIT IGG
RF-ET13'CL, RHEUMATOID FACTOR
MP1'CL, ANTI-HLA CLASS II (DQB1*0201)
VH ii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
PR1-3'CL, ANTI-NUCLEOSOME
1-42'CL, ANTI-SM HYBRIDOMA
D01'CL, ANTI-RH(D)
SM2K'CL, ANTI-SM
AD10/13'CL, ANTI-ERYTHROCYTE RH(D) 
PA1'CL, ANTI-CHROMATIN
2B9L'CL, ANTI-MURINE SERUM ALBUMIN
IgG+ CL'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
TW4.20'CL, ANTI-HUMAN TRANSFERRIN (KA = 1.70 X 10EXP9)
MAL'CL, POLYREACTIVE
JU17'CL, ANTI-IDIOTYPIC ANTIBODY
BBLC310.2'CL, ANTI-BACTERIAL LEVAN
28.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
P61B27'CL, REHEUMATOID FACTOR
H130-5'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
I16'CL, ANTI-RH(D)
H35-D1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
PE16'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
Ham-B'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
8G3'CL, ANTI-SM HYBRIDOMA
B/SB5-39'CL, ANTI-H2A/H2B
T6-626'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
RF-IP13'CL, RHEUMATOID FACTOR
clone 28'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
CLONE 13AD'CL, ANTI-LEUCINE ZIPPER
C15'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
3E5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
6A4'CL, ANTI-PSEUDOMONAS AERUGINOSA OUTER MEMBRANE PROTEIN I
RF2-11'CL, ANTI-IGG2A
2INH2'CL, ANTI-HUMAN INSULIN
Y12'CL, ANTI-SM HYBRIDOMA
3B12-1'CL, ANTI-HELA NUCLEAR EXTRACT
M-T310'CL, ANTI-HUMAN CD4
T10-649'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
E4-17'CL, ANTI-CON A
BrM11'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
kappa2'CL, ANTI-HUMAN THYROGLOBULIN
3F6'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
2INH7'CL, ANTI-HUMAN INSULIN
74.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
M03'CL, ANTI-RH(D)
I11'CL, ANTI-RH(D)
3707 E9'CL, ANTI-SHIGELLA DYSENTERIAE TYPE I
MICA 3'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
2B6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
BLI'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
VH iii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
HSCFV198'CL, ANTI-ACHR
DPD'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
LN2 189'CL, ANTI-MOUSE TYPE II COLLAGEN
R6B8K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
AC18'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
E29, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
126TO15K'CL, ANTI-THYROID PEROXIDASE (TPO)
3A5-1'CL, ANTI-METATOPE OF 4-4-20
mAb3G-10'CL, ANTI-HUMAN IL2 RECEPTOR TAC PROTEIN
R18-9'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
62'CL, ANTI-THYROGLOBULIN AUTOANTIBODY HYBRIDOMA
Brad-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
scFv-KJ16 wild-type'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
VH HER2'CL, ANTI-LAMIN B AUTOANTIBODY
s6H12'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
LB8'CL, ANTI-PASTEURELLA PNEUMOTROPICA HYBRIDOMA
SA-4B'CL, ANTI-TITIN AUTOANTIBODY
MF8 (VH4.22-JH4)'CL, RHEUMATOID FACTOR
RF3-5A'CL, ANTI-IGG1
SCFV198'CL, ANTI-ACHR
B/SB5-3'CL, ANTI-H4
Meso 4, ANTI-MESOTHELIN-POSITIVE CELLS (BUT NOT RECOMBINANT MESOTHELIN)
Sulf-5'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
GB4v1.0, ANTI-CD19
7G7'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
JSJ-1, ANTI-POLYAMINE, CROSS REACTS WITH PUTRESCINE AND SPERMINE
H151-31D10'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
AD21'CL, ANTI-ERYTHROCYTE RH(D) 
8.18-C5'CL, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
H130-6'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
23'CL, ANTI-INSULIN
F4'CL, ANTI-MOUSE TYPE II COLLAGEN
Fab-7, ANTI-HUMAN PROTEIN C
F01'CL, ANTI-RH(D)
AT13/5'CL, ANTI-CD38, A SURFACE ANTIGEN ON MYELOMA CELLS
2D10'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
A1'CL, AB3 (SEE NOTES)
2INL3'CL, ANTI-HUMAN INSULIN
MICA 4'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
L71'CL, ANTI-HUMAN CD4
304'CL, ANTI-INSULIN
CG-2'CL, ANTI-ERYTHROCYTE
S5P3'CL, RHEUMATOID FACTOR
L2H7'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
4A6'CL, ANTI-METATOPE OF 4-4-20
2C8'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT (TAC PROTEIN)
m95-99, ANTI-IDIOTYPIC
126TP13K'CL, ANTI-THYROID PEROXIDASE (TPO)
CP3 23-24'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
3T74, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
G10, ANTI-LYSOZYME HYBRIDOMA
82B6'CL, AUTOANTIBODY TO THYROGLOBULIN
kappa3'CL, ANTI-HUMAN THYROGLOBULIN
D14'CL, ANTI-RH(D)
bkv16'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
P13'CL, ANTI-PROTHROMBIN (KD = 1.4 X 10EXP-6)
2C5-3'CL, ANTI-88 KDA SPLICING FACTOR 53/4
234'CL, ANTI-P601E
CC49'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
CBL166.10.28'CL, ANTI-BACTERIAL LEVAN
NM3E2 scFv, ANTI-CD16
H01'CL, ANTI-RH(D)
O03'CL, ANTI-RH(D)
HuVHNIKNA'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (HIGH AFFINITY)
E73, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
mAb 123'CL, ANTI-INSULIN HYBRIDOMA
3B10'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
N901H/PLO123, ANTI-CD56
H152-42B11'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
CEA 66-E3'CL, ANTI-CARCINOEMBRYONIC ANTIGEN
G3D10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GM1, GA1, GALGALNAC-BSA, NLC4, 3-FL-BSA)
2INH10'CL, ANTI-HUMAN INSULIN
1-6'CL, ANTI-IGG2A
7B6'CL, ANTI-SM
E4-9'CL, ANTI-CON A
TEL14'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
2INL8'CL, ANTI-HUMAN INSULIN
Sulf-6'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
H2-4C2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
3G8'CL, ANTI-FECAL BACTERIA
2H1''CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
JV6'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
A3, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
A5'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
81B1'CL, AUTOANTIBODY TO THYROGLOBULIN
5H4'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 9.8X10EXP-8)
H35-C7'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
28B4.2'CL, CATALYTIC ANTIBODY
9H12.2'CL, ANTI-HISTONE
LES-B'CL, RHEUMATOID FACTOR
LG2-2'CL, ANTI-BOVINE THYMUS HISTONES (H2B RES. 1-13)
56R-7'CL, ANTI-3M-1
Z17VH3'CL, CD20
BLY3'CL, ANTI-CD19
2097'CL, ANTI-BACTERIAL LEVAN
115'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
kappa4'CL, ANTI-HUMAN THYROGLOBULIN
22.111.1'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
MICA 5'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
COL'CL, POLYREACTIVE
H220-11'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
FS-5'CL, COLD AGGLUTININ
2INH11'CL, ANTI-HUMAN INSULIN
1A1'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
D3'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
E37, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
J06'CL, ANTI-RH(D)
R1C8H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
mAb410.30F305'CL, POLYREACTIVE AUTOANTIBODY
H158-89H4'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
V86'CL, ANTI-MELANOMA
S8P10'CL, RHEUMATOID FACTOR
Dob1'CL, ANTI-STREPTOCOCCUS PNEUMONIAE 6B
REI-based resh. CAMPATH-9, ANTI-HUMAN CD4
HP25'CL, ANTI-PUBLIC IDIOTYPE HYBRIDOMA OF THE GAT SYSTEM
D1.3, ANTI-LYSOZYME HYBRIDOMA
F6, ANTI-MESOTHELIN
83.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
F1_1485'CL, ANTI-FRACTION 1
gammaR99'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
CD4-74'CL, ANTI-HUMAN RECOMBINANT CD4
J01'CL, ANTI-RH(D)
N901H, ANTI-CD56
7A9, ANTI-E-SELECTIN (AN ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1)
PE13'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
mAb63'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
SCH94.03'CL, AUTOANTIBODY REACTIVE WITH SPECTRIN, (4-HYRDOXY-3-NITROPHENYL)ACETYL, AND FLUORESCEIN, WHICH  PROMOTES CENTRAL NERVOUS SYSTEM REMYELINATION
126FH'CL, ANTI-THYROID PEROXIDASE (TPO)
316'CL, ANTI-P601E
126TP1H'CL, ANTI-THYROID PEROXIDASE (TPO)
Sulf-7'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
C04'CL, ANTI-RH(D)
Lym-1'CL, ANTIBODY USED IN CANCER THERAPY
C1'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
RF-7'CL, ANTI-IGG1 RHEUMATOID FACTOR
NANUC-1'CL, ANTI-NEUTROPHIL
L7'CL, AUTOANTIBODY
cDNA4-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
126TO6K'CL, ANTI-THYROID PEROXIDASE (TPO)
S1P9'CL, RHEUMATOID FACTOR
F1_1171'CL, ANTI-FRACTION 1
18.1'CL, ANTI-BACTERIAL LEVAN
LN2 15'CL, ANTI-MOUSE TYPE II COLLAGEN
kappa5'CL, ANTI-HUMAN THYROGLOBULIN
Ab17'CL, POLYREACTIVE AUTOANTIBODY
F5-2'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
2INH12'CL, ANTI-HUMAN INSULIN
AC37'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
AC15'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
hu PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
FIF, ANTI-I
MICA 6'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
CP8 B3-D3'CL, ANTI-BROMELINIZED MOUSE RED BLOOD CELL (BRMRBC) HYBRIDOMA
L47'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
C11'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
WG1'CL, ANTI-PROTEINASE 3
87.92.6'CL, ANTI-9B.G5 ANTIBODY HYBRIDOMA
126HK'CL, ANTI-THYROID PEROXIDASE (TPO)
FS-2'CL, ANTI-IDIOTYPIC 9G4
B/SB5-65'CL, ANTI-H2A/H2B
131TP15H'CL, ANTI-THYROID PEROXIDASE (TPO)
'CL, ANTI-MELANOMA
RF34, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
124'CL, ANTI-P601E
417.F28'CL, MONOREACTIVE
Vl HER1'CL, ANTI-LAMIN B AUTOANTIBODY
S4P11'CL, RHEUMATOID FACTOR
LES, RHEUMATOID FACTOR
CLONE 1B4'CL, ANTI-HUMAN RED BLOOD CELL
kappa6'CL, ANTI-HUMAN THYROGLOBULIN
AH80-5, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
752'CL, ANTI-P601E
37-63'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
L01'CL, ANTI-RH(D)
34-2B'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
H50'CL, ANTI-LAMININ
LS4'CL, ANTI-PR2 RBC AUTOANTIBODY
H61-15'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
ARM'CL, ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN
RF-SJ4'CL, MONOREACTIVE RHEUMATOID FACTOR
L2 12B'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
VS2'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
RF-ET12'CL, RHEUMATOID FACTOR
RF-IP4'CL, RHEUMATOID FACTOR
82B6b'CL, AUTOANTIBODY TO THYROGLOBULIN
MOPC-467, ANTI-FLAGELLIN
7C5'CL, ANTI-SM HYBRIDOMA
11A10'CL, ANTI-SM HYBRIDOMA
W5.1B4.4'CL, ANTI-IDIOTYPIC ANTIBODY
Ab25'CL, ANTI-THYROGLOBULIN AUTOANTIBODY
CH10'CL, ANTI-E. COLI
RF-IP12'CL, RHEUMATOID FACTOR
2D12'CL, ANTI-LA PROTEIN (SS-B)
ALN/11/53'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
1-7-3'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
WRD8'CL, RHEUMATOID FACTOR
4.18'CL, KIM11.4
D30'CL, ANTI-RH(D)
RA-2-L21'CL, RHEUMATOID FACTOR
7A4-1/212 SCA'CL, ANTIBODY CATALYSES HYDROLYSES OF P-CHLOROPHENYL ESTER 3
aCD3'CL, ANTI-CD3
bkv22'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
RF-ET5'CL, RHEUMATOID FACTOR
MICA 7'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
FK-001'CL, ANTI-PSEUDOMONAS AERUGINOSA EXOTOXIN A HYBRIDOMA
11IC6'CL, AUTOANTIBODY TO THYROGLOBULIN
RA-1-DT7'CL, RHEUMATOID FACTOR
H37-60'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
H220-1'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
2INH13'CL, ANTI-HUMAN INSULIN
M2 88'CL, ANTI-MOUSE TYPE II COLLAGEN
19A5'CL, ANTI-RH(D)
SP1.5'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
clone 5'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
D76, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
VH HER1'CL, ANTI-LAMIN B AUTOANTIBODY
126TO8K'CL, ANTI-THYROID PEROXIDASE (TPO)
1261P5K'CL, ANTI-THYROID PEROXIDASE (TPO)
7-1'CL, ANTI-IGG2A
10I'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
EL-14'CL, ANTI-FACTOR VIII
13D2'CL, ANTI-RH(D)
clone 31'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
N01'CL, ANTI-RH(D)
MRA7H'CL, ANTI-HISTONE
THY-32'CL, ANTI-HUMAN THYROGLOBULIN
WR1.102'CL, ANTI-THYROID PEROXIDASE
CB 334'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
CL-O'CL, ANTI-ERYTHROCYTE
C3'''CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=2.4X10EXP9)
VLREN'CL, CD5+
kappa7'CL, ANTI-HUMAN THYROGLOBULIN
L11-1A1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
N61'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
RF-MR41'CL, RHEUMATOID FACTOR
Hb-6, ANTI-FOETAL HAEMOGLOBIN (HBF)
H36-8'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
2-9'CL, ANTI-IGG2A
YSE'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
136/9'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
I09'CL, ANTI-RH(D)
36-18'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
HG2B10H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
FLO, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
CB 105'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
4D12'CL, ANTI-SM HYBRIDOMA
F30-4'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
RF-4'CL, ANTI-IGG1 RHEUMATOID FACTOR
19.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
5D1'CL, ANTI-HUMAN PROCOLLAGENASE
I04'CL, ANTI-RH(D)
RF5-3'CL, ANTI-IGG2A
E3-MPO'CL, ANTI-MYELOPEROXIDASE
H107, ANTI-HUMAN H FERRITIN
P01'CL, ANTI-RH(D)
1H6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
RF6-4'CL, ANTI-IGG2A
E12, ANTI-MESOTHELIN
RF-ET6'CL, RHEUMATOID FACTOR
E03, ANTI-LYSOZYME HYBRIDOMA
9F2H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA)
YTH 34.5HL'CL, ANTI-HUMAN LYMPHOCYTE HYBRIDOMA
THY-33'CL, ANTI-HUMAN THYROGLOBULIN
C1'CL, ANTI-MOUSE TYPE II COLLAGEN
S4 10H'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
3a4D10'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS
WR1.112'CL, ANTI-THYROID PEROXIDASE
126CH'CL, ANTI-THYROID PEROXIDASE (TPO)
2INH14'CL, ANTI-HUMAN INSULIN
BMA 0310EUCIV2'CL, ANTI-HUMAN T-CELL RECEPTOR HUMANIZED ANTIBODY
3910'CL, ANTI-OESTRONE-3-GLUCURONIDE
2-4'CL, ANTI-IGG2A
L36'CL, AUTOANTIBODY
RF9-11A'CL, ANTI-IGG1
11/32'CL, ANTI-PROGESTERONE HYBRIDOMA
145-2C11'CL, ANTI-MOUSE CD3 COMPLEX
19'CL, ANTI-INSULIN
126TO9K'CL, ANTI-THYROID PEROXIDASE (TPO)
Oak-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
G08, ANTI-LYSOZYME HYBRIDOMA
4B4'CL, ANTI-SM AUTOANTIBODY HYBRIDOMA
kappa8'CL, ANTI-HUMAN THYROGLOBULIN
B/SB5-41'CL, ANTI-H4
MP12'CL, ANTI-HLA CLASS II (DRB1*11)
Vl REN'CL, ANTI-CARDIOLIPIN/BETA 2 GLYCOPROTEIN I AUTOANTIBODY
RF34'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
L69'CL, ANTI-HUMAN CD4
slkv1'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
HA-6'CL, ANTI-ERYTHROCYTE
vl6-19'CL, ANTI-IGG2A RHEUMATOID FACTOR
NC1/34HL'CL, ANTI-SUBSTANCE P
Anti-Leu3a'CL, ANTI-CD4 (INHIBITING THE BINDING OF HIV GP120 TO CD4)
13D10'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 2.8X10EXP-8)
JV6, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
A1, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
CP5 A23-3'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
ARMVl'CL, ANTI-MYELIN ASSOCIATED PROTEIN
CP5 A21-1'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
RF-ET7'CL, RHEUMATOID FACTOR
D07'CL, ANTI-RH(D)
2H1, ANTI-CRYPTOCOCEUS NEOFORMANS, AN ENCAPSULATED FUNGUS THAT CAUSES MENINGOENCEPHALITIS
ASWS1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
2INH15'CL, ANTI-HUMAN INSULIN
MAR'CL, POLYREACTIVE
Z119VH5'CL, CD20
HP22'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
SM3, ANTI-CARCINOMA-ASSOCIATE MUCIN, RECOGNIZING THE PEPTIDE PDTRP
2C8'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
PA2'CL, ANTI-CHROMATIN
RF1-9'CL, ANTI-IGG2A
SS269, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
1D5'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
AIG'CL, ANTI-FC IGG
R01'CL, ANTI-RH(D)
G03, ANTI-LYSOZYME HYBRIDOMA
CUR, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
NN3'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
A73, ANTI-SMRNP
F1_1355'CL, ANTI-FRACTION 1
IAG-1, ANTI-POLYAMINE, CROSS REACTS WITH SPERMIDINE
1F6'CL, ANTI-FECAL BACTERIA
RA-2-L5'CL, RHEUMATOID FACTOR
IC5-3A4'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
B10H2'CL, ANTI-THYROGLOBULIN AUTOANTIBODY HYBRIDOMA
hsigkvm148'CL, ANTI-BETA-AMYLOID
L2-5D2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
I12'CL, ANTI-RH(D)
2INH16'CL, ANTI-HUMAN INSULIN
2INH1'CL, ANTI-HUMAN INSULIN
SO1'CL, ANTI9-HLA-DQ3
3D8L'CL, ANTI-MURINE SERUM ALBUMIN
B'2 (VH3-JH4)'CL, RHEUMATOID FACTOR
2H7'CL, ANTI-CD20 CELL SURFACE PHOSPHOPROTEIN HYBRIDOMA
D23'CL, POLYREACTIVE AUTOANTIBODY HYBRIDOMA
scFv-KJ16 mut7'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
M2 76'CL, ANTI-MOUSE TYPE II COLLAGEN
311, ANTI-TYPE II PNEUMOCOCCAL POLYSACCHARIDE
131TP14H'CL, ANTI-THYROID PEROXIDASE (TPO)
VL A121, ANTI-CD34
3B12-2'CL, ANTI-88 KDA SPLICING FACTOR 53/4
RF-MR20'CL, RHEUMATOID FACTOR
417.F21.5'CL, POLYREACTIVE
126TP5H'CL, ANTI-THYROID PEROXIDASE (TPO)
S3 12D'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
N901H/KOL, ANTI-CD56
Y238 scFv'CL, ANTI-P21 RAS
L16'CL, ANTI-POLYDT, CARDIOLIPIN, AND SSDNA
TE32'CL, ANTI-CTP3
ML1'CL, ANTI-POLYDT, AND SSDNA
TE33'CL, ANTI-CTP3
AL1-3'CL, ANTI-POLYCATION
AL3-5'CL, ANTI-POLYCATION
AL1-2'CL, ANTI-POLYCATION
AL3-4'CL, ANTI-POLYCATION
AL3-3'CL, ANTI-POLYCATION
AL3-8'CL, ANTI-POLYCATION
AL3-2'CL, ANTI-POLYCATION
Py20, ANTI-PHOSPHOTYROSYLPROTEIN
Py42, ANTI-PHOSPHOTYROSYLPROTEIN
scFv13, ANTI-BETA-GALACTOSIDASE
2E9E9'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
1C4C9'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
1G8G10'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
Py2, ANTI-PHOSPHOTYROSYLPROTEIN
1G1B6'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
6B10D2'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
Py69, ANTI-PHOSPHOTYROSYLPROTEIN
Py54, ANTI-PHOSPHOTYROSYLPROTEIN
L16'CL, ANTI-POLYDT, CARDIOLIPIN, AND SSDNA
TE32'CL, ANTI-CTP3
ML1'CL, ANTI-POLYDT, AND SSDNA
TE33'CL, ANTI-CTP3

